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Methods

Identification of deleterious mutations within three
human genomes
Sung Chun1 and Justin C. Fay1,2,3
1

Computational Biology Program, Washington University, St. Louis, Missouri 63108, USA; 2Department of Genetics,
Washington University, St. Louis, Missouri 63108, USA
Each human carries a large number of deleterious mutations. Together, these mutations make a significant contribution to
human disease. Identification of deleterious mutations within individual genome sequences could substantially impact an
individual’s health through personalized prevention and treatment of disease. Yet, distinguishing deleterious mutations
from the massive number of nonfunctional variants that occur within a single genome is a considerable challenge. Using
a comparative genomics data set of 32 vertebrate species we show that a likelihood ratio test (LRT) can accurately identify
a subset of deleterious mutations that disrupt highly conserved amino acids within protein-coding sequences, which are
likely to be unconditionally deleterious. The LRT is also able to identify known human disease alleles and performs as well
as two commonly used heuristic methods, SIFT and PolyPhen. Application of the LRT to three human genomes reveals
796–837 deleterious mutations per individual, ;40% of which are estimated to be at <5% allele frequency. However, the
overlap between predictions made by the LRT, SIFT, and PolyPhen, is low; 76% of predictions are unique to one of the
three methods, and only 5% of predictions are shared across all three methods. Our results indicate that only a small
subset of deleterious mutations can be reliably identified, but that this subset provides the raw material for personalized
medicine.
[Supplemental material is available online at http://www.genome.org.]
Mutations that impact an organism’s ability to survive and reproduce are deleterious and must be eliminated by natural selection in order to ensure the long-term survival of a species (Lynch
et al. 1993). Removal of deleterious mutations from the gene pool
requires a substantial number of genetic deaths and incurs a considerable reproductive cost (Muller 1950). However, many deleterious mutations persist for hundreds of generations or more before
they are removed, since their effects are largely masked in the
heterozygous state (Simmons and Crow 1977).
The presence of deleterious mutations within the human
population has a significant impact on human health. Inbreeding
causes an increase in child morbidity and mortality and suggests
that each human carries a sufficient number of deleterious mutations that, if made homozygous, would together result in premature death (Morton et al. 1956). In addition, most mutations
that cause monogenic diseases are clearly deleterious. Diseases
with a complex genetic basis are also likely to be affected by deleterious mutations. In support of this possibility, rare variants that
have been associated with complex human diseases are often
predicted to be deleterious (Cohen et al. 2004; Ahituv et al. 2007).
However, even when rare variants have been associated with human disease, there is considerable uncertainty as to which rare
variants are responsible for the association.
A number of methods have been developed to identify deleterious and/or disease-causing mutations within protein-coding
sequences. These methods predict whether an amino acid altering
mutation is deleterious or disease causing based on physicochemical properties (Grantham 1974), population frequency (Ohta
1973; Fay et al. 2001), protein structure (Chasman and Adams
2001; Sunyaev et al. 2001; Wang and Moult 2001), and crossspecies conservation (Chasman and Adams 2001; Ng and Henikoff
3
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2001; Sunyaev et al. 2001). For a comprehensive review of methods, see Ng and Henikoff (2006). While these methods can identify 40%–90% of disease-causing mutations, the rate of falsepositives is uniformly high, 10%–20% (Ng and Henikoff 2006).
The high rate of false-positives may be caused by most predictions
relying on some aspect of sequence conservation, which is difficult
to accurately model. One factor that confounds evolutionary
models is that not all disease-causing mutations are conserved,
presumably due to compensatory changes elsewhere in the protein
(Kondrashov et al. 2002). A further complication is that mutations
in highly conserved sequences do not always produce phenotypes
that are easily noticeable (Ahituv et al. 2007; Hillenmeyer et al.
2008). Regardless of the cause, the accuracy of cross-species conservation depends on both the assumptions and parameterizations
of evolutionary models that relate sequence conservation to fitness
or function (Ng and Henikoff 2006; Care et al. 2007).
Genome sequencing of a large number of closely related
species makes it possible to develop better parameterized evolutionary models that more accurately predict human deleterious
mutations. Closely related species minimize the frequency of
compensatory changes that enable functional sites to diverge.
Conversely, a large number of species maximize the phylogenetic
distance among taxa required to accurately distinguish selectively
constrained sites from neutral sites that have not yet diverged
(Eddy 2005). A number of models use putatively neutral classes of
sites to distinguish functionally constrained and neutral sites
based on closely related genomes (e.g., Stone et al. 2005; Asthana
et al. 2007; Doniger et al. 2008). Although evolutionary models
may not identify all disease-causing mutations, they provide
a probabilistic framework in which the subset of disease-causing
mutations that disrupt highly conserved amino acid positions can
be accurately identified given enough phylogenetic information.
Prediction of deleterious mutations within individual human
genomes has the potential to impact both the prevention and
treatment of disease at an individual level. Although a number of
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human genomes have been sequenced, Table 1. Summary of deleterious mutations found in three individuals and the reference
the number of nonsynonymous variants genome
predicted to impact protein function varTested
Deleterious
ies widely. Using SIFT (Ng and Henikoff
2003), 14% (1455) of nonsynonymous
Heterozygotes
High-quality
Heterozygotes
(percent)a
variants
Number
(percent)a
Numberb
variants within the Venter genome were Genome
predicted to impact protein function (Ng
7534
5645
52
796 (14%)
78
et al. 2008). Using PolyPhen (Ramensky J. Craig Venter
James D. Watson
7353
5417
49
816 (15%)
76
et al. 2002), 7.3% (;770) of nonsyn- Han Chinese
7462
5707
58
837 (15%)
83
onymous variants within the Watson ge- Reference
NA
10,689
NA
838 (8%)
NA
nome were predicted to impact protein
a
The frequency of heterozygotes was derived from genotype calls in the original publications.
function (Wheeler et al. 2008). However,
b
The percentage of tested mutations that are deleterious is shown in parentheses.
comparison of these predictions is difNA, Not available.
ficult since they are based on different
data, different models, and use different
relative to a neutral model, where there is no difference between
methods to control for sequencing errors, a potentially important
the nonsynonymous and synonymous substitution rate (Methsource of false-positives (Ng et al. 2008).
ods). Most of the deleterious mutations, 59%–62%, were inTo identify and characterize deleterious mutations present
dividual specific (Fig. 1). In addition, the majority of deleterious
within an individual genome, we examined three recently semutations, 76%–83%, were present in a heterozygous state.
quenced human genomes (Levy et al. 2007; Wang et al. 2008;
However, the true frequency of heterozygotes is likely higher, since
Wheeler et al. 2008). Using a likelihood ratio test (LRT) (Doniger
et al. 2008), we identified 796–837 amino acid altering mutations
homozygotes are more easily identified than heterozygotes, and
some heterozygotes may be misclassified as homozygotes (Levy
per genome that disrupt highly conserved amino acids. Comparison with two other methods, SIFT and PolyPhen, revealed only
et al. 2007; Wang et al. 2008; Wheeler et al. 2008). In addition
to deleterious mutations present within the three individual
a small amount of overlap among the three methods and suggests
that multiple methods should be used when trying to identify
genomes, we identified another set of 838 deleterious mutations
that occur in the reference genome in comparison to either the
deleterious mutations in humans.
Venter, Watson, or Chinese genomes (Methods). Out of the 838
deleterious mutations, 474 were specific to the reference genome
Results
and were not present in the Venter, Watson, or Chinese genome.
Consistent with previous studies (Fay et al. 2002), the freIdentification of deleterious mutations
quency of deleterious mutations is lower on the X chromosome
in three human genomes
compared with the autosomes, 10.5% relative to 18.1%, reMutations that alter evolutionarily conserved sequences are likely
spectively (P < 0.05, Fisher’s exact test). Only 14 out of 1928 delto be deleterious and have a negative impact on fitness. To diseterious mutations were found on the X relative to 119 out of 8761
tinguish functionally constrained and unconstrained amino acid
neutral variants. These results indicate that partially recessive
positions, we generated a comparative genomics data set using 32
deleterious mutations are more rapidly eliminated from the X
vertebrate species (Methods). Multiple alignments of orthologous
chromosome.
protein-coding sequences were generated for 18,993 human genes.
The synonymous substitution rate was estimated to be 12.2 across
An abundance of common deleterious mutations
all species and 4.7 across the eutherian clade, placental mammals,
Most deleterious mutations are maintained at low-population
similar to previous studies (Methods). The large amount of difrequencies due to negative selection (Kryukov et al. 2007). Howvergence among these species implies that unconstrained amino
ever, 435/1928 (23%) of the deleterious mutations are present in
acid positions should rarely be conserved across species, and
more than one of the three genomes, suggesting that at least some
mutations that alter conserved amino acids are likely to be deleof the deleterious mutations may be common (Fig. 1). Consistent
terious.
with negative selection, the fraction of nonsynonymous alleles
To identify deleterious mutations present within an individual human genome, we examined nonsynonymous variants
present within the genomes of J. Craig Venter, James D. Watson,
and a Han Chinese male (Levy et al. 2007; Wang et al. 2008;
Wheeler et al. 2008). To eliminate sequencing errors, we only used
a subset of high-quality alleles, a phred quality score of 60 or greater
for the Venter and Chinese genome, and a variant score of 70 or
greater for the Watson genome (Wheeler et al. 2008). After eliminating 24%–26% of variants that occur in regions without a sufficient number of aligned orthologs for accurate inference of
functional constraint, less than 10 eutherian species, we analyzed
5417–5707 nonsynonymous variants per individual.
Using a LRT, we identified between 796 and 837 deleterious
mutations in the three diploid genomes, ;15% of those tested (P <
0.001; Table 1). The LRT compares the probability of the data under
a conserved model, allowing for any level of selective constraint,
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Figure 1. Venn diagram of deleterious mutations identified in J. Craig
Venter, James D. Watson, and a Han Chinese individual. The percentage
of individual-specific deleterious mutations found in each genome is
shown in parentheses.
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Table 2.
classes

Deleterious mutations are enriched in rare frequency
Rare alleles

Genome
J. Craig Venter
James D. Watson
Han Chinese

Common allelesa

Tested

Deleteriousb

Tested

Deleteriousb

766
940
703

213 (28%)
303 (32%)
186 (26%)

3066
2632
3438

583 (19%)
513 (19%)
651 (19%)

a
Common alleles include those that are shared between any of the
three genomes.
b
Percent deleterious is shown in parentheses.

that are deleterious is lower for those that are shared among the
three individuals, 19%, relative to those that are individual specific, 26%–32% (Table 2). To more accurately quantify the frequency of deleterious mutations we used the HapMap Phase II
and Phase III panels and found that 1121/1928 deleterious mutations (58%) are common, greater than 5% allele frequency in at
least one of the three HapMap panels. Surprisingly, many deleterious mutations have reached intermediate to high frequencies;
925 (48%) are at frequencies >20%, 472 (24.5%) are at frequencies >50%, and 163 (8.5%) are at frequencies >80%.
Deleterious mutations can become common if their effects
are buffered by recently duplicated genes. Degeneration of recently
duplicated genes is expected under both nonfunctionalization and
subfunctionalization models of gene duplication (Lynch and Force
2000). Tabulating all deleterious mutations that occur in recently
duplicated proteins (Methods), 70 out of 1928 deleterious mutations
(3.6%) occur in duplicated genes (Fig. 2A). Although there is a significant enrichment of deleterious relative to neutral alleles in
duplicated genes (x2, P < 0.01), only seven of the common deleterious alleles occur in duplicated genes. Thus, most common
deleterious mutations are not buffered from selection by gene
duplication.
If negative selection is weak, a substantial number of deleterious mutations can become common by random genetic drift. To
examine whether common deleterious alleles are under weaker selection than those that are rare, we calculated the frequency of
deleterious mutations in perfectly conserved sites, the frequency
of deleterious mutations that caused radical amino acid substitutions, defined by a BLOSUM62 score of #2, and the frequency
of deleterious mutations for which the deleterious allele was observed in one or more noneutherian species. Combining the data
from all three genomes, rare deleterious mutations are more likely
to occur in perfectly conserved sites, are more often radical, and are
less likely to be present in noneutherian species (x2 test, P < 0.01;
Fig. 2B). This result suggests that rare deleterious mutations are
under stronger negative selection than common alleles, consistent
with both empirical and theoretic studies (Keightley and EyreWalker 2007; Kryukov et al. 2007; Boyko et al. 2008). However,
some of the common deleterious mutations may also be falsepositives.

testing. A P-value cutoff of 0.01 results in a prediction of 1120–
1197 deleterious mutations within the three genomes, but is also
expected to include a higher number of false-positives, 54–57 per
individual.
Sequencing errors can also result in false-positive predictions.
Given a phred quality score cutoff of 60, 0.47 false-positives are
expected due to sequencing errors in the Venter genome (Methods). For the reference genome, 53 false-positives are expected,
assuming three nucleotide substitution errors per 1 Mbp (Schmutz
et al. 2004). The rate of sequencing errors is more difficult to know
for the Watson and Chinese genomes, since a complex series
of quality filters were used and quality values derived from
new sequencing technologies may not be entirely accurate (e.g.,
Brockman et al. 2008).
To empirically estimate the impact of sequence errors on
prediction of deleterious mutations, we tested whether the frequency of deleterious mutations is affected by the quality score
cutoff. Consistent with a minor effect of sequencing errors, the
fraction of deleterious mutations in the Venter genome is nearly
constant for phred values greater than 60 (Supplemental Fig. S1A).
High-quality nonsynonymous heterozygous variants from each
genome were split into two groups of roughly equal numbers using
their quality scores. In each case the proportion of variants called
deleterious was slightly higher (0.3%–3.6%) in the group with
higher compared with lower quality values (Supplemental Fig. S1).

Estimation of the false-positive rate
A number of factors could lead to false-positive prediction of
deleterious mutations. To estimate the rate of false-positives, we
examined multiple hypothesis testing, sequencing errors, and
model assumptions. Given an uncorrected P-value cutoff of 0.001
and the number of tests (Table 1), we estimate five to six falsepositive predictions per individual due to multiple hypothesis

Figure 2. Characteristics of deleterious mutations. (A) Deleterious
mutations (n = 1928) are more likely to occur in recently duplicated genes
relative to neutral variants (n = 8287). (B) Mutations at perfectly conserved sites, mutations that cause radical amino acid changes, defined by
BLOSUM62 # 2, and mutations to amino acids that are not observed
outside of eutherian mammals are more frequent among rare (n = 807)
compared with common deleterious mutations (n = 1121).
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This result suggests that few of the deleterious mutations identified
by the likelihood ratio can be attributed to sequencing errors.
False-positive predictions can also arise if the assumptions of
the LRT are violated. The LRT assumes a neutral substitution rate
estimated from synonymous sites, and so false-positive predictions
may occur for variants that occur in positions with lower than
average mutation rates. Two significant sources of variation in
mutation rates are methylated CpG sites and regional variation
across the genome (Chimpanzee Sequencing and Analysis Consortium 2005; Gaffney and Keightley 2005). To examine the effect
of regional variation across the genome, we estimated the number
of deleterious mutations using a synonymous substitution rate of
10.1, two standard deviations below the mean. The standard deviation due to regional variation in mutation rates was obtained
from the coefficient of variation (8.75%) reported for mouse–rat
divergence in ancestral repeats at a scale of 1 Mb (Gaffney and
Keightley 2005). To account for overestimation of the synonymous substitution rate due to methylated CpG sites, all CpG-prone
sites were eliminated and the synonymous rate was found to be
reduced by 12% in the mammalian clade and by 5% overall. Because regional variation in mutation rates generated a greater reduction in the synonymous rate, 1–10.1/12.2 (17%), we used
a total synonymous rate of 10.1 and found 621 deleterious mutations remain significant in the Venter genome. This implies that
only 22% (621/796) of highly conserved amino acid positions
could be due to low mutation rates rather than negative selection.
The true percentage is much lower since, only a small fraction of
sites tested, ;2.5%, are expected to have a mutation rate two
standard deviations below the genome average.
The false-positive rate can also be estimated using a set of
negative controls. Previous studies estimated the rate of falsepositives using nonsynonymous SNPs present in humans (Ng
and Henikoff 2002) or substitutions between humans and other
mammals (Ramensky et al. 2002). Given that a significant number
of deleterious mutations and sequencing errors may be present
within any sequenced genome, we generated a set of negative controls using 39,028 nonsynonymous substitutions that occurred
after orangutan but before chimpanzee split off from the lineage
leading to humans (Methods). The LRT identified 2633 substitutions (6.7%) as deleterious (P < 0.001). This is lower than
that estimated for both PolyPhen (9%) (Sunyaev et al. 2001) and
SIFT (20%) (Ng and Henikoff 2002), but is still much higher than
that caused by sequencing errors or variation in mutation rate.
When the negative controls were subdivided into three classes by
the severity of amino acid changes using Grantham’s distance
(Grantham 1974), the LRT identified more conservative substitutions (8.3%) compared with moderate (6.1%) or radical substitutions (5.1%).

conservative disease-causing mutations (30.2% and 29.7%, respectively). Such differences are not due to varying availability of
comparative genomic data. A similar fraction of mutations lack
sufficient comparative genomic data in all three classes of amino
acid changes.

Comparison to SIFT and PolyPhen predictions
A variety of methods have been developed to specifically identify
mutations that cause human disease. Two of the most commonly
used methods, SIFT (Ng and Henikoff 2003) and PolyPhen
(Ramensky et al. 2002), use heuristic measures of cross-species
conservation along with the type of amino acid change to predict
human disease mutations. SIFT uses a median conservation score
rather than synonymous sites to measure protein conservation.
PolyPhen also uses a normalized cross-species conservation score
and combines this with a variety of protein structural features
when available. Both methods use nonredundant protein databases and so make use of a much more diverse set of species than
the LRT.
Compared with the 796 deleterious mutations identified by
the LRT, SIFT predicted 890 intolerable mutations and PolyPhen
predicted 768 possibly damaging and 555 probably damaging
mutations in the Venter genome (Methods). The overlap between
these predictions is low but significantly greater than chance (Fig.
3). Out of all predictions, 18%, 30%, and 28% were specific to
PolyPhen, SIFT, and the LRT, respectively, and 93 mutations (5%)
were predicted by all three methods. The overlap of all three
methods is greater than the 5.9 mutations (0.3%) expected by
chance. Each of the methods predicted a similar fraction of

Estimation of the false-negative rate
The false-negative rate was estimated using known disease-causing
missense mutations in the OMIM database (Methods). Out of 5493
mutations, 3947 (71.9%) are significant by the LRT (P < 0.001). The
false-negative rate of the LRT (28%) is similar to that of both SIFT
(31%) (Ng and Henikoff 2002) and PolyPhen (31%) (Sunyaev et al.
2001). Of the 1546 disease mutations that were not identified, 644
(42%) occur at positions with little or no comparative genomic
data (fewer than 10 eutherian mammals or a synonymous substitution rate #2). Although the LRT does not explicitly account
for the type of amino acid change, the false-negative rate is lower
for radical disease-causing mutations (25.2%) than for moderate or
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Figure 3. Comparison of SIFT, PolyPhen, and the likelihood ratio test
(LRT) predictions. (A) Venn diagram of the number of predictions made by
the three methods. Probably damaging mutations were used for PolyPhen. Numbers below and above each line are for the complete set of 7534
high-quality variants present within the Venter genome and a subset of
4303 where all three methods generated a prediction, respectively. (B)
Overlap between the LRT and SIFT predictions based on the same alignments.
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mutations that were not predicted by the other two methods; 57%,
59%, and 61% of predictions made by PolyPhen, SIFT, and the LRT,
respectively, were not predicted by either of the two other methods.
The low overlap among predictions made by the LRT, SIFT,
and PolyPhen is not due to differences in coverage. Out of the 7534
high-quality mutations present within the Venter genome, PolyPhen, SIFT, and the LRT generated predictions for 6746 (90%),
5401 (72%), and 5645 (75%) mutations, and all three methods
generated predictions for 4303 (57%) mutations. Most of these
differences are likely the result of each method requiring a sufficient number and diversity of aligned sequences in order to make
a prediction, each method using a different set of sequences and
alignments. Despite the differences in coverage, the overlap
among the methods remains low when only the 4303 mutations
with predictions made by all three methods were compared (Fig. 3).
To determine whether the low overlap can be attributed to
alignment differences, SIFT was run using the same alignments as
those used for the LRT. Figure 3B shows that tuning SIFT’s median
conservation score to generate a similar number of deleterious
predictions as the LRT improved the overlap between SIFT and the
LRT from 269 (19%) to 404 (34%). Thus, many, but not all of
the differences between SIFT and the LRT are due to differences in
the sequences and/or alignments used to identify evolutionary
conserved amino acids.
The remaining differences between SIFT and the LRT predictions can be attributed to a number of factors. Out of 392
mutations that were predicted deleterious by the LRT but not SIFT,
226 (58%) occurred in highly conserved proteins and were not
identified as intolerable by SIFT due to the high median conservation score of the protein. SIFT uses the median conservation
score of a protein to eliminate predictions based on highly similar
proteins. Because the LRT uses synonymous site divergence to
calibrate conservation, many cases are likely false-negative predictions made by SIFT. In 184/392 (47%) cases the amino acid
predicted to be deleterious by the LRT was found in one or more
vertebrate species outside of the eutherian mammals. Although
this indicates that these alleles are probably neutral in distantly
related species, the LRT implies that amino acid conservation
within the eutherian mammals is significant, and so the allele may
be deleterious in humans.
A number of factors are also likely to contribute to the 404
mutations predicted to be intolerable by SIFT that were predicted
neutral by the LRT. A total of 126/404 (31%) cases showed marginal significance by the LRT, (0.001 < P < 0.01). Some of these cases
may be due to the lower power of the LRT, since SIFT differentiates
between conservative and radical amino acid changes, a factor
known to be predictive of function (Stone and Sidow 2005). The
LRT may also have lower power for sites with a significant number
of missing species. A total of 133/404 (33%) cases occurred in
alignments for which there were not enough species to apply the
LRT, as defined by a total synonymous substitution rate less
than four. Because the LRT alignments are based mostly on closely
related mammalian species, some of these cases are likely falsepositive predictions made by SIFT. However, these predictions may
also be a consequence of forcing SIFT to use alignments from
closely related species and would not be predicted by SIFT when
run using its own set of alignments.

Discussion
Identification of deleterious mutations within individual genomes
has the potential to directly impact both health and reproductive

decisions. The wealth of comparative genomics data now available
makes it possible to rapidly identify all mutations that disrupt
highly conserved amino acid positions that are likely to be deleterious. Here, we have evaluated the ability of a LRT to identify
deleterious mutations within three human genomes. We identified
a similar number of deleterious mutations, 796–837, in three human genomes, and showed that only a handful are expected to
be false-positives due to sequencing errors or multiple hypothesis
testing. While the LRT performs as well as two other commonly
used methods, SIFT and PolyPhen, the overlap among predictions made by different methods is disturbingly low. Analysis of
these differences indicates that both the algorithms, as well as
the alignments used to identify conserved sites, make a significant contribution to the low overlap among predictions. Our
results suggest that multiple methods should be used to reliably identify deleterious mutations for association with human
disease.
The LRT is conceptually distinct from other comparative genomic methods. To our knowledge, all previous methods designed
to identify deleterious mutations (for review, see Ng and Henikoff
2006) rely on heuristic procedures to distinguish sites within a
protein that are conserved from those that are not conserved. This
is achieved by selecting sequences that are not too closely or too
distantly related to the sequence of interest and comparing the
degree of conservation at the site of interest to other sites in the
protein. The advantage of this approach is that the phylogenetic
relationship and evolutionary distance among the sequences is not
required. However, there are also limitations to this approach since
no distinction is made between distantly related proteins that are
highly conserved and closely related proteins that have evolved
rapidly. Although proteins can always be selected that show a desired degree of similarity, compensatory changes are more likely to
have occurred in distantly related proteins. In comparison, the LRT
was designed to explicitly model phylogenetic relationships using
a probabilistic framework and to minimize compensatory changes,
which are thought to be common (Kondrashov et al. 2002) and can
cause false-negatives by using closely related vertebrate species:
mammals, chicken, frog, and fish.
The LRT also differs from other comparative genomic methods in that all amino acid changes are treated the same rather than
weighting radical and conservative amino acid changes differently.
While this is expected to reduce the power of the LRT, empirically,
both the false-positive and the false-negative rates of the LRT are
lower for radical relative to conservative amino acid changes. This
may be a consequence of the genetic code and other mutational
parameters being correlated with the ratio of radical to conservative amino acid changes (Dagan et al. 2002).
The LRT performs similar to two other commonly used
comparative methods, SIFT (Sunyaev et al. 2001) and PolyPhen
(Ng and Henikoff 2002). We found that the LRT was able to identify 72% of known disease-causing mutations, slightly higher than
that reported for PolyPhen (69%) and SIFT (69%). However, it
should be noted that these numbers are not directly comparable
since accuracy depends on how it is measured. For example, SIFT
and PolyPhen detected 70% and 72% of deleterious mutations
when applied to the same protein mutation database (Bromberg
and Rost 2007). Many, 644/1546 (42%), of the disease mutations
that were not identified by the LRT can be attributed to the absence
of sufficient comparative genomic data, i.e., not enough species.
The remaining cases may be attributed to compensatory changes
that allowed sites that cause human disease to change in nonhuman species.
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The false-positive rate of the LRT is estimated to be lower than
that estimated for SIFT and PolyPhen. While few false-positives are
expected due to sequencing errors and multiple hypothesis testing,
we found 6.7% of negative controls were called deleterious by the
LRT. The rate of false-positives is lower than that estimated for both
SIFT (20%–30%) and PolyPhen (9%–28%) (Sunyaev et al. 2001; Ng
and Henikoff 2002; Bromberg and Rost 2007). However, some of
these differences may be due to the use of different negative controls. Regardless of slight methodological differences, the frequency of putatively neutral mutations called deleterious (6.7%) is
only half the fraction predicted to be deleterious in the Venter,
Watson, and Chinese genomes (14%–15%), suggesting a false
discovery rate of nearly 50% within individual genomes. Yet, the
rate of false-positives estimated from the negative controls may be
an overestimate, since not all human ancestral substitutions may
be neutral. Some ancestral substitutions may be weakly deleterious
mutations that became fixed by genetic drift, a process that can be
exacerbated by a small effective population size. Other ancestral
substitutions may be advantageous mutations that alter the
function of previously conserved amino acids due to a change in
the environment. Thus, ancestral substitutions provide an upper
bound on the number of false-positive predictions.
The potentially high rate of false-positives may explain the
large number of common alleles predicted to be deleterious in
the three genomes. Similar to the negative controls, some of the
common alleles may occur in sites that have been under negative
selection in primates and other mammals but have recently become neutral along the human lineage. However, it is also possible
that some deleterious mutations have increased in frequency due
to hitchhiking along with recent positively selected mutations.
Further work will be needed to address the impact of positive selection on the number and frequency of deleterious mutations.
Despite similar performance of the LRT, SIFT, and PolyPhen,
the overlap among predictions made by the three methods is low,
5% (Fig. 3). The majority of differences are not due to cases where
one or more methods did not make a prediction due to limited or
insufficient data; the overlap remains low for cases where all three
methods generated predictions (Fig. 3). Inspection of cases where
the three methods disagreed revealed two general explanations for
the disagreements. First, distantly related species can have a strong
influence on the prediction of deleterious mutations and each
method uses a different set of distantly related species. Distantly
related species tend to have a large effect since fewer sites are
conserved and they are more likely to carry the deleterious allele
due to compensatory changes. The impact of distantly related
species is significant, since each method measures conservation
using a different set of distantly related species. Both SIFT and
PolyPhen can use any homologous protein sequence and generate
alignments using different nonredundant databases of protein
sequences. In contrast, the LRT only uses a few nonmammalian
species: chicken, frog, and five fish species (Supplemental Fig. S2).
One of the goals of developing the LRT was to avoid using distantly
related species that are more likely to contain compensatory
changes, which may produce variable results depending on arbitrary decisions as to which distantly related species to use. However, the use of closely related species has its own set of disadvantages (see below).
A second class of disagreements are sites that are perfectly
conserved within each of the different alignments but are slightly
above or below cutoffs used by the LRT, SIFT, or PolyPhen. These
borderline cases may also depend on which sequences are included
in the alignment, because SIFT and PolyPhen use a site-specific
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score that is normalized to conservation within the rest of the
protein and the P-value of the LRT explicitly depends on which
species are included, since this determines the expected rate of
change as measured by the synonymous substitution rate. One of
the goals of developing the LRT was to accurately account for each
species’ contribution to the likelihood using the synonymous
substitution rate. The drawback of this approach is that the increase in accuracy depends on a number of parameters that must
be estimated from the data.
The LRT’s use of closely related species may result in falsepositive and false-negative predictions not made by either SIFT or
PolyPhen. In order to use closely related species, the LRT uses
synonymous sites to estimate the neutral substitution rate. However, the accuracy of this estimate depends on many factors. While
we showed that CpG sites and large-scale regional variation in
mutation rates are unlikely to have large effects on the prediction
of deleterious mutations, other types of mutational variation were
not accounted for (e.g., Hodgkinson et al. 2009). Even slight
changes in the estimated neutral substitution rate will affect some
predictions. Consequently, despite the advantages of using closely
related species, many borderline cases may be false-positives or
false-negatives. Borderline cases may be more accurately resolved
by using additional closely related genomes or by inclusion of
distantly species.
Is the power of the LRT limited by the amount of comparative
genomic data? For perfectly conserved sites, the fraction of mutations called deleterious does not increase with the number of species
used to identify conserved sites (Supplemental Fig. S3). However,
the fraction of mutations predicted to be deleterious increases
with the number of species used for sites that are not perfectly
conserved (Supplemental Fig. S3). This suggests that additional
species will only increase the power of the LRT to detect sites that
are not perfectly conserved. Increasing the power to detect semiconserved sites may be useful given the large number of human
disease alleles that occur at sites that are not perfectly conserved.
What fraction of deleterious mutations was not identified?
Not considering false-negatives due to compensatory changes and
other modeling assumptions, deleterious mutations could be
missed due to a lack of alignments or low power associated with the
available alignments. To estimate the number of deleterious
mutations that did not reach a P-value of <0.001, i.e., low power,
we estimated the number of true positives as a function of the false
discovery rate. Supplemental Figure S4 shows that as the P-value
cutoff is lowered, the estimated number of true positives plateaus
to ;1100 mutations, suggesting that nearly 75% of deleterious
mutations were identified at a P-value cutoff of 0.001. The number
of deleterious mutations missed due to a lack of sufficient alignments is more difficult to know. Only 74%–76% of mutations were
tested in the Venter, Watson, and Chinese genomes due to a paucity of mammalian homologs. However, a smaller proportion of
these may be deleterious, since they are more likely to occur in
new, recently duplicated genes. An alternative method of estimating the number of deleterious mutations is based on allele
frequency and avoids deficiencies due to a lack of alignments (Fay
et al. 2001). Applying the allele frequency estimate to the Venter
genome indicates that the LRT identified 62% of rare deleterious
mutations (Methods). However, many factors other than the
presence of suitable alignments may contribute to the difference
between the allele frequency and the LRT estimates.
Despite different sequencing technologies, we found a very
similar number of deleterious mutations within three human
genomes, 796–837. Previous reports predicted ;770 (Wheeler
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et al. 2008) and 1455 (Ng et al. 2008) missense mutations within
the Watson and Venter genome, respectively. However, these differences can be almost entirely attributed to differences between
the methods used to predict deleterious mutations and/or the
quality score cutoffs used to eliminate sequencing errors. Using
the same set of high-quality variants tested by the LRT, SIFT predicted 890, 769, and 861, and PolyPhen predicted 555, 501, and
496 deleterious mutations in the Venter, Watson, and Chinese genomes, respectively. While the coefficient of variation is greater
than one for both SIFT and PolyPhen, it is less than one for the LRT.
The standard deviation of the number of deleterious mutations
identified by the LRT is 20.5 and is less than that expected assuming a Poisson distribution, 28.6. This supports the idea that
truncating selection mediated by synergistic epistasis facilitates
the removal of deleterious mutations (Crow and Kimura 1979).
However, not all features of deleterious mutations were similar
among the three genomes. The fraction of deleterious or neutral
mutations within recently duplicated genes was much smaller in
the Chinese compared with the other two genomes. This difference may be reflective of the greater difficulty of identifying SNPs
in duplicated sequences using short-read sequencing technologies.
In conclusion, the abundance of mutations that disrupt
highly conserved amino acid positions within three healthy human genomes implies that in most cases their phenotypic effects
are either small or that the mutations are recessive. However, many
of the mutations may produce large effects when homozygous.
Although only a small number of mutations were predicted deleterious by the LRT, SIFT, and PolyPhen, the use of all three methods
should provide an excellent source of candidates for association
with human disease. Finally, since just over half of all deleterious
mutations were found to be common, our results support the
possibility that rare variants make a significant contribution to
complex human diseases (Pritchard 2001; Kryukov et al. 2007).

Methods
Comparative genomic data set
Multiple sequence alignments of protein-coding sequences were
generated from 32 vertebrate species (Supplemental Fig. S2).
Orthologous protein sequences were downloaded from Ensembl
(ftp://ftp.ensembl.org/pub/release-49/emf/ensembl_compara/
homologies/), originally inferred by TreeBest (Vilella et al. 2009),
aligned using MUSCLE (Edgar 2004), and then backtranslated into
nucleotide alignments. All known selenocysteine residues were
masked. After removing alignments with too few orthologous, <10
eutherian mammals, there were 18,993 alignments with an average of 16.5 species per alignment.

Likelihood ratio test (LRT)
The LRT was used to compare the null model that each codon is
evolving neutrally, with no difference in the rate of nonsynonymous (dN) to synonymous (dS) substitution, to the alternative
model that the codon has evolved under negative selection with
a free parameter for the dN/dS ratio. The log-likelihood ratio (LLR)
of the conserved relative to the neutral model is:
LLR = log

^ SÞ
LðDjT; u; d N = Cd
LðDjT; u; d N = d S Þ

where D is an alignment of a single codon, T is a phylogenetic tree,
dN and dS are the nonsynonymous and synonymous substitution
^ is the maximum likelihood estimate of
rates of the codon, and C

dN/dS. The synonymous rate and u, the parameters of the rate
matrix, were estimated from the concatenated set of all codons
without gaps, as described in the next paragraph. P-values were
obtained by comparing twice the log likelihood ratio to a x2 distribution with one degree of freedom. The LRT was implemented
using the MG94 codon model (Muse and Gaut 1994) combined
with an HKY85 model (Hasegawa et al. 1985) to account for unequal base frequencies and differences in the rates of transitions
and transversions. This was accomplished within a maximum
likelihood framework using HyPhy (Pond et al. 2005).
The synonymous substitution rate was estimated from gapfree concatenated alignments of 1227 genes completely conserved
across all 32 species, a total of 54 kb, using the same model as that
described above. The estimated dS values for the human to the
mouse–rat ancestor (0.46), mouse lineage (0.10), and rat lineage
(0.13) are similar to previous estimates, 0.457, 0.095, and 0.101,
respectively (Cooper et al. 2005).
To make the predictions of the LRT available to the community for every potential nonsynonymous variant in the human
genome, we applied it to 10,073,284 codons for which there were
a sufficient number of aligned species. A total of 5,828,045 sites
were significant (P < 0.001 and dN/dS < 1). Note that a substantial
number of nonsynonymous variants at these positions may not be
predicted deleterious if the mutant allele being tested is present
within one or more of the eutherian mammals. The complete data
set can be obtained by request from the investigators or downloaded from the corresponding investigator’s website (http://www.
genetics.wustl.edu/jflab/).

Identifying deleterious mutations
A complete catalog of SNPs were obtained for J. Craig Venter
and a Han Chinese male from their respective websites (http://
www.jcvi.org/cms/research/projects/huref/ and http://yh.genomics.
org.cn), and for James D. Watson directly from Dr. David Wheeler
(Baylor College of Medicine, Houston, TX). Nonsynonymous and
synonymous SNPs were identified using known genes in Ensembl
release 49. Coding SNPs in ambiguous reading frames, due to
overlap of adjacent genes or frame shifts between known splice
variants, or in known pseudogenes, were excluded.
To avoid sequencing errors, stringent quality filters were applied. Since quality scores were not available for each allele in the
Venter genome, these were independently tabulated by mapping
SNPs in the Venter genome to individual sequencing reads (ftp://
ftp.ncbi.nih.gov/pub/TraceDB/Personal_Genomics/Venter/) and
obtaining phred quality values for each allele from the sum of the
quality scores supporting each allele. For each SNP, a 1000-bp
flanking sequence around the SNP was extracted from the reference genome (NCBI build 36) and queried with MegaBlast against
the Venter reads. Of the high-scoring blast hits (E-value < 1 3 10-100),
only reads with perfect alignment across the 40 bp flanking each
SNP were retained. Out of the original nonsynonymous SNPs, 22%
failed to support a combined phred score of $60 and at least two
supporting reads. By comparison to experimentally validated SNPs
(Levy et al. 2007), this high-quality set of SNP has a lower rate of
false-positive (0 out of 15) but a higher rate of false-negatives (4 out
of 19) compared with the list of SNPs originally reported in Venter.
The SNPs in the Chinese genome were also filtered using a phred
quality cutoff of 60. SNPs in the Watson genome are associated
with a variant score that is similar yet not identical to a phred
quality score (Wheeler et al. 2008). Based on the distribution of
quality variant scores, we used a quality variant cutoff of 70 for the
Watson genome (Supplemental Fig. S1B).
Deleterious mutations were predicted by nonsynonymous
SNPs that disrupt significantly constrained codons defined by the
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LRT (P < 0.001) and a number of subsequent filters (Supplemental
Table S1). First, positions with low power, <10 eutherian mammals,
were eliminated. Second, a small number of sites with dN significantly greater than dS were discarded. Finally, positions where the
derived deleterious allele occurred in another eutherian species
were eliminated. Deleterious mutations were assigned to either the
tested or reference genome depending on whether the reference or
variant allele resulted in a lower dN/dS ratio. The total number of
deleterious mutations includes all heterozygous or homozygous
positions that differ from the reference genome except for homozygous positions where the reference allele rather than the variant
allele was inferred to be deleterious. The number of deleterious mutations in the reference genome is the nonredundant set identified
by comparison with the Venter, Watson, and Chinese genomes.

False-positive rate
The false-positive rate due to sequencing errors was estimated using phred quality scores. Using a phred quality cutoff of 60, 0.027
false-positive SNPs per 1 Mb are expected in the Venter genome.
This calculation is based on an average phred quality score of 75.7.
A total of 10.4 million codons were tested and 56.2% of these, 17.6
Mb, were estimated to be significantly constrained codons (P <
0.001), based on a random sample of 6357 codons. Using the estimated rate of sequencing errors and the total number of constrained
codons, we expect a total of 0.47 false-positive SNPs due to sequencing errors. Using the same approach, 1.06 false-positives are
estimated to occur in the Chinese genome. Using an error rate of
three nucleotide substitutions per 1 Mbp for the reference genome
(Schmutz et al. 2004), a total of 52.8 false-positives are expected.
To empirically estimate the rate of false-positives, the frequency of deleterious mutations was estimated for heterozygous
sites with lower and higher quality values. Only heterozygous sites
were used, since homozygous variants are less likely to be deleterious but are more likely to have high-quality values. For the
Venter, Watson, and Chinese genome the quality value splits were
157, 129, and 97, respectively (Supplemental Fig. S1). In each case,
the estimated number of false-positives was zero, since the fraction
of deleterious mutations was higher using alleles with higher
quality values.
The false-positive rate was also estimated using a set of negative controls. A negative control set was defined by ancestral
amino acid substitutions that were inferred by maximum parsimony to have occurred along the lineage leading to humans after
the split with the orangutan lineage but before the split with the
chimpanzee lineage. We identified 39,028 amino acids that are the
same between human and chimpanzee and between orangutan
and macaque but differ between human and orangutan. The LRT
was applied to the negative control set as if these ancestral substitutions were missense mutations present in the human population. The sequences of the primate species used to identify the
set of negative controls (human, chimp, orangutan, and macaque)
were excluded from the LRT. To examine different types of amino
acid changes, the negative controls were subdivided into three
classes by the severity of amino acid changes using the Grantham
scale (Grantham 1974). Conservative amino acid changes were
defined by a Grantham score of 50 or below, moderate changes by
a Grantham score of 51 to 100, and radical changes by a score of
greater than 100.

tions to genomic coordinates. Each OMIM gene was mapped to
a single representative RefSeq protein that provided the best match
to the positions and amino acids of curated OMIM alleles. To eliminate potential mapping errors, we filtered out amino acid variants
that are more than one mutation away from the mapped codon in
the reference genome. Out of 9231 missense variants in OMIM, we
mapped 5493 variants (59.5%) to the genome and tested each of
them using the LRT. Identification of conservative, moderate, and
radical amino acid changes was quantified using the same set of
Grantham scores as that used for the analysis of false-positives.

Allele frequency
Filtered nonredundant allele frequencies in three HapMap analysis
panels (CEU, CHB, and YRI) were downloaded from http://www.
hapmap.org (Phase II+III, release 26) and used to identify SNPs
with at least 5% frequency in the CEU, CHB, or YRI panels (The
International HapMap Consortium 2007). Permission for the responsible use of the HapMap Phase III data was obtained from the
International HapMap Consortium (D Altshuler and R Gibbs, pers.
comm.).

Recent gene duplication
Recently duplicated genes were defined by human paralogs with
>95% protein identity. Percent identity was calculated from human paralogs within the MUSCLE-generated multiple alignments
of homologs from Ensembl. A total of 1232 human genes were
identified as having at least one recently duplicated paralog in the
human genome.

SIFT and PolyPhen predictions
SIFT 3.0 was downloaded and run locally to predict deleterious
mutations in Venter using two different modes. First, SIFT was run
using an independent set of alignments built using the TrEMBL
39.8 protein sequence database. Note that while TrEMBL contains
many human sequence variants, SIFT eliminates highly similar
sequences (Ng and Henikoff 2002). SIFT was able to generate
alignments and predictions without errors for 6539 out of 7534
nonsynonymous variants. Filtering by the median conservation
cutoff of 3.5 as in Ng et al. (2008), we obtained 5401 predictions
and a total of 890 variants predicted to affect protein function.
Second, SIFT was run with the same set of alignments used by the
LRT. The median conservation score was set to 4.0 so that the
number of SNPs predicted to impact protein function was similar
to the number predicted by the LRT.
PolyPhen 1.15 was obtained from Shamil Sunyaev (Harvard
Medical School) and run locally to generate predictions for the
Venter genome. SWISS-PROT 56.8 and the latest version of the
BLASTNR, PDB, and DSSP databases were used as input. PolyPhen
generated predictions for 6746 nonsynonymous variants and
called 768 possibly damaging and 555 probably damaging. Because PolyPhen does not generate allele-specific predictions, some
of these predictions may be for Venter-reference differences, where
the derived, deleterious allele is present in the reference but not
Venter. Both SIFT and the LRT avoided this issue because they both
generate allele-specific predictions.

Estimation of rare deleterious mutations
False-negative rate
The false-negative rate was estimated using disease-causing missense mutations in OMIM database. The coordinates of OMIM
allelic variants were converted from protein-based residue posi-
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To estimate the number of deleterious mutations using allele frequencies, we compared the ratio of nonsynonymous (N) to synonymous (S) variants for rare versus common frequency classes
(Fay et al. 2001). Because allele frequencies were not always available
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and nonsynonymous alleles may be more often selected for genotyping, we used double hits in the dbSNP database as a proxy for
rare versus common alleles, where double hits are defined by SNPs
with at least two submissions. Within the three human genomes,
the N/S ratio of double hit variants was 0.84–0.85 and nondoublehit variants was 1.01–1.08, leading to an average estimate of 689
(18.6%) rare deleterious mutations. After accounting for the fact
that only 48% of all deleterious mutations predicted by the LRT are
present as double hits within dbSNP, and so do not contribute to the
frequency calculation, we estimate that 62% of all rare deleterious
mutations were identified by the LRT (0.52*816/689).
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